Design Therapeutics (DSGN) Change in Acquisitions & Divestments (2020 - 2026)

Design Therapeutics has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $27.5 million in Q2 2026.

• Change in Acquisitions & Divestments for Q2 2026 came in at $27.5 million, down 53.96% year-over-year; the trailing twelve-month figure through Jun 2026 was $233.2 million (down 17.05% YoY), and the FY2025 annual result was $314.9 million, up 14.72% from the prior year.
• Change in Acquisitions & Divestments retreated to $27.5 million in Q2 2026, from $45.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $94.5 million in Q1 2025 and troughed at $490000.0 in Q1 2022.
• A 5-year average of $57.3 million and a median of $63.4 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
• The largest YoY upside for Change in Acquisitions & Divestments was 30020.0% in 2022 against a maximum downside of 98.26% in 2022.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $60.2 million in 2022, then soared by 32.36% to $79.7 million in 2023, then retreated by 16.97% to $66.2 million in 2024, then increased by 14.91% to $76.1 million in 2025, then sank by 63.85% to $27.5 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $27.5 million in Q2 2026, $45.0 million in Q1 2026, and $76.1 million in Q4 2025.